PDE7A-IN-1
Product Specifications
Target
PDE
Related Pathways
Metabolism
Bioactivity
PDE7A-IN-1 (Compound 26) is an orally active PDE7A inhibitor with an IC50 value of 3.7 nM. By inhibiting sclerostin, PDE7A-IN-1 significantly enhances bone mineral density, making it suitable for studies on osteoporosis and related bone metabolic disorders.
Molecular Formula
C25H26ClN5O2
Molecular Weight
463.96
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS6149679-01 0.1 mL
SKP1A (S-phase Kinase-associated Protein 1, Cyclin-A/CDK2-associated Protein p19, Organ of Corti Protein 2, OCP-2, Organ of Corti Protein II, OCP-II, RNA Polymerase II Elongation Factor-like Protein, SIII, Transcription Elongation Factor B, p19A, p19skp1,
Ask
View Details MBS6149679-02 5x 0.1 mL
SKP1A (S-phase Kinase-associated Protein 1, Cyclin-A/CDK2-associated Protein p19, Organ of Corti Protein 2, OCP-2, Organ of Corti Protein II, OCP-II, RNA Polymerase II Elongation Factor-like Protein, SIII, Transcription Elongation Factor B, p19A, p19skp1,
Ask
View Details ![Goat Polyclonal Goat anti-Rat IgG2c Secondary Antibody [DyLight 594]](https://cdn.genprice.uk/genprice/uk/genprice4.webp)
NBP2-68492DL594 0.5 mL
Goat Polyclonal Goat anti-Rat IgG2c Secondary Antibody [DyLight 594]
Ask
View Details